NO‐Donating Oximes Relax Corpora Cavernosa Through Mechanisms Other than Those Involved in Arterial Relaxation
- 1 July 2014
- journal article
- Published by Oxford University Press (OUP) in The Journal of Sexual Medicine
- Vol. 11 (7) , 1664-1674
Abstract
INTRODUCTION: Erectile dysfunction (ED), as well as many cardiovascular diseases, is associated with impaired nitric oxide (NO) bioavailability. Recently, oxime derivatives have emerged as vasodilators due to their NO-donating capacities. However, whether these oximes offer therapeutic perspectives as an alternative NO delivery strategy for the treatment of ED is unexplored. AIMS: This study aims to analyze the influence of formaldoxime (FAL), formamidoxime (FAM), and cinnamaldoxime (CAOx) on corporal tension and to elucidate the underlying molecular mechanisms. METHODS: Organ bath studies were carried out measuring isometric tension on isolated mice corpora cavernosa (CC), thoracic aorta, and femoral artery. After contraction with norepinephrine (NOR), cumulative concentration-response curves of FAL, FAM, and CAOx (100 nmol/L-1 mmol/L) were performed. MAIN OUTCOME MEASURES: FAL-/FAM-induced relaxations were evaluated in the absence/presence of various inhibitors of different molecular pathways. RESULTS: FAL, FAM, and CAOx relax isolated CC as well as aorta and femoral artery from mice. ODQ (soluble guanylyl cyclase-inhibitor), diphenyliodonium chloride (nonselective flavoprotein inhibitor), and 7-ethoxyresorufin (inhibitor of CYP450 1A1 and NADPH-dependent reductases) substantially blocked the FAL-/FAM-induced relaxation in the arteries but not in CC. Only a small inhibition of the FAM response in CC was observed with ODQ. CONCLUSIONS: This study shows for the first time that NO-donating oximes relax mice CC. Therefore, oximes are a new group of molecules with potential for the treatment of ED. However, the underlying mechanism(s) of the FAL-/FAM-induced corporal relaxation clearly differ(s) from the one(s) involved in arterial vasorelaxation. Pauwels B, Boydens C, Decaluwé K, and Van de Voorde J. NO-donating oximes relax corpora cavernosa through mechanisms other than those involved in arterial relaxation. J Sex Med 2014;11:1664-1674Keywords
This publication has 27 references indexed in Scilit:
- Divergent Molecular Mechanisms Underlay CO- and CORM-2-Induced Relaxation of Corpora CavernosaThe Journal of Sexual Medicine, 2012
- Aldehyde Oxidase Functions as a Superoxide Generating NADH Oxidase: An Important Redox Regulated Pathway of Cellular Oxygen Radical FormationBiochemistry, 2012
- Nitric oxide synthases: regulation and functionEuropean Heart Journal, 2011
- Nω-hydroxy-l-arginine homologues and hydroxylamine as nitric oxide-dependent vasorelaxant agentsEuropean Journal of Pharmacology, 2005
- Therapeutic strategies for optimizing PDE-5 inhibitor therapy in patients with erectile dysfunction considered difficult or challenging to treatInternational Journal Of Impotence Research, 2004
- Activation and potentiation of the NO/cGMP pathway by NG‐hydroxyl‐L‐arginine in rabbit corpus cavernosum under normoxic and hypoxic conditions and ageingBritish Journal of Pharmacology, 2003
- Involvement of NO in the Endothelium-Independent Relaxing Effects of Nω-Hydroxy-l-arginine and Other Compounds Bearing a C=NOH Function in the Rat AortaThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Microsomal Cytochrome P450 Dependent Oxidation of N-Hydroxyguanidines, Amidoximes, and Ketoximes: Mechanism of the Oxidative Cleavage of Their CN(OH) Bond with Formation of Nitrogen OxidesBiochemistry, 1998
- Inhibition of nitrovasodilator- and acetylcholine-induced relaxation and cyclic GMP accumulation by the cytochrome P-450 substrate, 7-ethoxyresorufinCanadian Journal of Physiology and Pharmacology, 1992
- Cytochrome P450 catalyzes the oxidation of Nω-hydroxy-L-arginine by NADPH and O2 to nitric oxide and citrullineBiochemical and Biophysical Research Communications, 1992